Voices
Ann-Kathrin Eisfeld Appointed Director of Precision Genomics Clinical Transformation at OSUCCC-James – Ohio State Hematology
Ann-Kathrin Eisfeld/The Ohio State University

Ann-Kathrin Eisfeld Appointed Director of Precision Genomics Clinical Transformation at OSUCCC-James – Ohio State Hematology

Ohio State Hematology shared on X:

“Congrats to Ann-Kathrin Eisfeld appointed as Director of Precision Genomics Clinical Transformation The James at Ohio State. An internationally recognized leader in leukemia genomics and precision medicine, her expertise makes her the ideal person to lead this initiative and advance personalized care.”

Ohio State Hematology

Other articles featuring Ann-Kathrin Eisfeld on OncoDaily.

Medically reviewed Jul 20, 2026 by Mariam Khachatryan, MD
Ann-Kathrin Eisfeld cancer Director of Precision Genomics Clinical Transformation Ohio State Hematology OncoDaily Oncology The James at Ohio State